BioNTech SE is 3.3x more valuable than Arcellx, Inc. by market capitalization ($22.18 B vs $6.73 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ACLX | BNTX |
|---|---|---|
| Market cap | $6.73 B | $22.18 B |
| US-listed rank | #1180 | #582 |
| Revenue (latest FY) | $22.29M | - |
| Net income (latest FY) | -$228.93M | - |
| Net margin | -1027.3% | - |
| SEC filings | 448 | 548 |
BioNTech SE is 3.3x more valuable than Arcellx, Inc. by market capitalization ($22.18 B vs $6.73 B).
Full pages: Arcellx, Inc. and BioNTech SE, or browse the full rankings.